Risperidone versus clozapine in the treatment of schizophrenic patients with acute symptoms: A double blind, randomized trial
- 1 January 1994
- journal article
- clinical trial
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 18 (1), 129-137
- https://doi.org/10.1016/0278-5846(94)90029-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Combined serotonin‐5‐HT2 and dopamine‐D2 antagonism in schizophrenia: Clinical, extrapyramidal and neuroendocrine response in a preliminary study with risperidone (R 64 766)Human Psychopharmacology: Clinical and Experimental, 1990
- Pilot Clinical Investigation of Risperidone in the Treatment of Psychotic PatientsPharmacopsychiatry, 1990
- The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64 766) in the treatment of chronic psychosis: An open dose-finding studySchizophrenia Research, 1989
- Thymosthenic Agents, A Novel Approach in the Treatment of SchizophreniaThe British Journal of Psychiatry, 1989
- Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patientsPsychopharmacology, 1989
- A RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECTSActa Psychiatrica Scandinavica, 1970